CARBOPLATIN | N020452 | CORDENPHARMA
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Qilu Pharma, Inc. as the US Agent of Qilu Pharmaceutica... FDA-2017-P-2231 Qilu Pharma, Inc. as the US Agent of Qilu Pharmaceutical Co., Ltd. submitted this petition on April 7, 2017 requesting that the FDA designate Carboplatin Injection in multiple strengths (50 MG/5ML, 150 MG/15ML, 450 MG/45ML, and 600 MG/60ML) from PHARMACHEMIE BV with application number A077269 as an | 505(q) | 2017-04-10 | Withdrawn | Qilu Pharma |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.